Research — Rare Subtypes
VISION EXPANDS WITH NEARLY 500 PATIENTS REGISTERED
Publication of VISION Data Report
ENROLLMENT STATS
421 Participants
The VISION Platform (VISION) is in its third year of recruitment with nearly 500 registered participants from around the globe. VISION’s power is elevating the patient perspective by collecting patient- reported data. Working with an interdisciplinary and inter-institutional steering committee with patients and caregivers at its core, the VISION team published data from the second year of the VISION Registry in the 2023 VISION Data Report which can be accessed below. The VISION team is currently working with partners and stakeholders to incorporate VISION into ongoing clinical trials. Additionally, VISION continues to work with its Steering Committee to incorporate patients’ feedback and develop and implement new features to meet the needs of the ocular melanoma (OM) community. Key learnings from the VISION Platform can be found in the 2023 VISION Registry Data Report ( https://melanoma.org/2023visiondatareport ).
37 States 9 Countries
4
Made with FlippingBook Ebook Creator